ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Inhibition of ITGB5 Protects Hepatocytes from Ischemia Reperfusion Injury

M. Dogan1, S. Naik1, C. Watkins1, A. Bajwa1, V. Mas2, J. Eason3, C. Kuscu1, C. Kuscu1

1Transplant Research Institute, James D. Eason Transplant Institute, Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN, 2Surgery, University of Maryland, Baltimore, MD, 3University of Tennessee/Methodist Transplant Institute, Memphis, TN

Meeting: 2022 American Transplant Congress

Abstract number: 661

Keywords: Ischemia

Topic: Basic Science » Basic Science » 14 - Ischemia Reperfusion

Session Information

Session Name: Ischemia Reperfusion

Session Type: Poster Abstract

Date: Saturday, June 4, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 5:30pm-7:00pm

Location: Hynes Halls C & D

*Purpose: Liver transplantation is the best treatment option for patients with end-stage liver disease (ESLD). Despite the increasing interest to the machine reperfusion, cold preservation is still main method for organ procurement. Moreover, transplant centers are using high-risk donors that are known to be associated with exacerbated ischemia-reperfusion (IRI) injury and worse outcomes due to the increasing gap between available donors and recipients. Hence, understanding the molecular mechanisms associated with liver IRI is very critical to identify novel target genes which can be manipulated (e.g., either by available drugs or new techniques such as gene editing) during IRI.

*Methods: HepG2 cell line has been used for in-vitro IRI model and CRISPR functional genomic screening approach due its unlimited growth potential and its universal utilization in liver research. Chemical agents antimycin and hydrogen peroxide were used to mimic ischemia conditions and reperfusion was established by replacing the oxygenated nutrients rich media. Brunella CRISPR library with >70,000 gRNAs was utilized at MOI:0.3 to knock out single gene in a given cells. IRI resistant cells were flow sorted and gRNA frequencies were analyzed by “MAGeCK” integrative analysis pipeline after the next-generation sequencing (NGS). Later, bulk RNA-sequencing was performed for ITGB5 knock-out (KO) HepG2 and control cells to investigate the potential downstream mechanism.

*Results: We identified 8 significant genes from CRISPR screening. One out of 8 showed enriched gRNA profile and 7 out of 8 displayed depleted gRNAs profile after the I/R injury (p < 10*e-5 and FDR < 0.05 (Fig A)). Enriched gene called, ITGB5 whose inhibition has been previously shown to attenuate renal IRI (McCurley et al, JASN,2017) was also discovered in our study. Pathway analysis from differentially expressed genes (DEG) in ITGB5-KO compared to control cells showed the upregulation of cell cycle and proliferation related pathway as a defense mechanism against hepatic IRI (Fig B). GTPase activity related pathway were down regulated in IRI resistant ITGB5 KO cells (Fig C).

*Conclusions: This is the first study that demonstrates the utility and applicability of CRISPR based library screening and the role of ITGB5 against hepatic IRI.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Dogan M, Naik S, Watkins C, Bajwa A, Mas V, Eason J, Kuscu C, Kuscu C. Inhibition of ITGB5 Protects Hepatocytes from Ischemia Reperfusion Injury [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/inhibition-of-itgb5-protects-hepatocytes-from-ischemia-reperfusion-injury/. Accessed May 9, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences